Proposed merger of British Biotech and RiboTargets
21 March 2003
The boards of British Biotech and RiboTargets are pleased to announce that they have agreed the terms of a Merger of the two companies to create a Merged Group with a pro-forma market capitalisation of £52 million and Net Cash as at 28 February of £43.5 million, with a further £7.9 million receivable from certain RiboTargets shareholders upon completion of the Merger.
View the full release (PDF - 660KB).
---ends---
